Ivan Victoria

Iván Victoria 3 collaborations

Aleix Prat 2 collaborations

José Manuel González de Aledo-Castillo 1 collaboration

Ainara Arcocha 1 collaboration

Ana Isabel Martinez-Puchol 1 collaboration

Cristina Sánchez 1 collaboration

Pedro Jares 1 collaboration

Gabriel Felipe Rodríguez 1 collaboration

Núria Viñolas 1 collaboration

Roxana Reyes 1 collaboration

Noemí Reguart 1 collaboration

Joan Antón Puig-Butillé 1 collaboration

Mercedes Marín-Aguilera 1 collaboration

Òscar Reig 1 collaboration

Maria Milà-Guasch 1 collaboration

Albert Font 1 collaboration

Montserrat Domènech 1 collaboration

Alejo Rodríguez-Vida 1 collaboration

Joan Carles 1 collaboration

Cristina Suárez 1 collaboration

Aránzazu González Del Alba 1 collaboration

Natalia Jiménez 1 collaboration

Núria Sala-González 1 collaboration

Maria José Ribal 1 collaboration

Sandra López 1 collaboration

Olatz Etxaniz 1 collaboration

Geòrgia Anguera 1 collaboration

Pablo Maroto 1 collaboration

Pedro Luis Fernández 1 collaboration

Begoña Mellado 1 collaboration

Javier García-Corbacho 1 collaboration

Alberto Indacochea 1 collaboration

Azucena E González Navarro 1 collaboration

Débora Moreno 1 collaboration

David Pesántez 1 collaboration

Laura Angelats 1 collaboration

Andrea Modrego-Sanchez 1 collaboration

Esther Sanfeliu 1 collaboration

Oleguer Castillo 1 collaboration

Paula Blasco 1 collaboration

Laura Mezquita 1 collaboration

Nuria Viñolas 1 collaboration

Miquel Nogué 1 collaboration

Patricia Galván 1 collaboration

Barbara Adamo 1 collaboration

Neus Basté 1 collaboration

Tamara Sauri 1 collaboration

Manel Juan 1 collaboration

Francesco Schettini 1 collaboration

Publications (3)

Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice.

The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer.

Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.

Réseau de co-auteurs